Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID-19 Registry Japan

INTRODUCTION: Several randomized controlled trials have compared the effectiveness of favipiravir with that of placebo. However, evidence regarding its effect on nonsevere, early-stage coronavirus disease 2019 (COVID-19) remains insufficient. METHODS: We used the COVID-19 Registry Japan, a nationwid...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuzuki, Shinya, Hayakawa, Kayoko, Doi, Yohei, Shinozaki, Tomohiro, Uemura, Yukari, Matsunaga, Nobuaki, Terada, Mari, Suzuki, Setsuko, Asai, Yusuke, Yamada, Gen, Saito, Sho, Shibata, Taro, Kondo, Masashi, Izumi, Kazuo, Hojo, Masayuki, Mizoue, Tetsuya, Yokota, Kazuhisa, Nakamura-Uchiyama, Fukumi, Saito, Fumitake, Sugiura, Wataru, Ohmagari, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934685/
https://www.ncbi.nlm.nih.gov/pubmed/35307811
http://dx.doi.org/10.1007/s40121-022-00617-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934685/
https://www.ncbi.nlm.nih.gov/pubmed/35307811
http://dx.doi.org/10.1007/s40121-022-00617-9

Ejemplares similares